Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Characteristics and Survival Outcomes in Patients With Small Cell Lung Cancer in Spain: An Analysis of the Thoracic Tumor Registry (2016-2025).

Archivos de bronconeumologia·2026
Same author

Characteristics and clinical outcomes of a nationwide cohort of patients with small cell lung cancer following first-line treatment: Real-world evidence.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Exploratory plasma ctDNA genomic biomarkers identified by whole-exome sequencing and a novel bioinformatics pipeline in advanced driver-negative NSCLC.

Scientific reports·2026
Same author

Two-year treatment-free sustained remission after chemo-immunotherapy in a 52-year-old male with recurrent <i>ARID1A</i>-mutant lung adenocarcinoma: a case report.

Translational lung cancer research·2026
Same author

Plasmatic CXCL13 as a biomarker of primary resistance to immunotherapy and impaired peripheral immunity in non-small cell lung cancer.

Biomarker research·2026
Same author

ARIAN protocol: a phase III study of sacituzumab and zimberelimab for the treatment of patients with non-small cell lung cancer.

Expert opinion on biological therapy·2026
Same journal

Ivonescimab: The Next United States Food and Drug Administration Project Optimus Flashpoint?

JTO clinical and research reports·2026
Same journal

Clinical Outcomes for Patients who Received Both Trastuzumab Deruxtecan (T-DXd) and Trastuzumab Emtansine (T-DM1) for HER2-Mutant non-Small Cell Lung Cancer.

JTO clinical and research reports·2026
Same journal

Trastuzumab Deruxtecan Induces Complete Pathological Response in Oligometastatic HER2-Mutant NSCLC: Case Report.

JTO clinical and research reports·2026
Same journal

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, <i>EGFR</i> Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial.

JTO clinical and research reports·2026
Same journal

Differential Treatment Effects by Smoking Status for NSCLC Therapies (2010-2023): A Meta-Analysis.

JTO clinical and research reports·2026
Same journal

Lung Adenocarcinoma Developing Pleomorphic Carcinoma With <i>ERBB3</i> Amplification After Acquired Resistance to Sotorasib: A Case Report.

JTO clinical and research reports·2026
See all related articles

Related Experiment Videos

Multidisciplinary Approach to Sexual Dysfunction in Persons With Lung Cancer-Spanish Lung Cancer Group Expert

Aylen Vanessa Ospina-Serrano1, Constanza Maximiano-Alonso1, Pau Guillén-Sentís2

  • 1Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.

JTO Clinical and Research Reports
|June 8, 2026
PubMed
Summary
This summary is machine-generated.

Sexual dysfunction is common in lung cancer patients but often overlooked. This consensus provides recommendations for a multidisciplinary approach to improve sexual health assessment and care for lung cancer survivors.

Keywords:
Cancer treatmentExpert consensusLung cancerSexual dysfunctionSurvivors

Related Experiment Videos

Area of Science:

  • Oncology
  • Sexual Medicine
  • Clinical Practice Guidelines

Background:

  • Sexual dysfunction (SD) is a frequent adverse effect of cancer treatment.
  • Sexual health assessment is not routinely integrated into the follow-up care of lung cancer (LC) patients.

Purpose of the Study:

  • To develop recommendations for a multidisciplinary approach to managing sexual dysfunction in lung cancer patients.
  • To address the lack of specific guidelines for sexual health assessment in LC survivorship.

Main Methods:

  • A formal consensus process was conducted by the Spanish Lung Cancer Group.
  • Mixed methods, including a modified Delphi technique and nominal group process, were employed.
  • A panel of 28 Spanish experts across various medical and psychological disciplines participated.

Main Results:

  • The consensus process involved two voting rounds and a final meeting.
  • Recommendations covered patient education, screening, follow-up, multidisciplinary team composition, referral criteria, and management strategies (pharmacologic and non-pharmacologic).
  • An 85% expert agreement threshold was used, with clinical experience guiding recommendations where evidence was limited.

Conclusions:

  • The developed suggestions aim to enhance clinical care for sexual health in lung cancer patients.
  • This consensus provides a framework to improve the quality of life for individuals with lung cancer.
  • The recommendations may facilitate the integration of sexual health assessment into routine oncologic follow-up.